Rajib Kumar Paul

Title: Rajib Kumar Paul: Innovator in Cannabinoid Receptor Activity Regulation

Introduction

Rajib Kumar Paul is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cannabinoid receptor activity regulation, holding a total of 4 patents. His work focuses on innovative methods to address various disorders and diseases associated with cannabinoid receptor activity.

Latest Patents

One of Rajib Kumar Paul's latest patents involves methods of regulating cannabinoid receptor activity-related disorders and diseases. This disclosure highlights the discovery of using fenoterol analogues to regulate cannabinoid (CB) receptor activity-related disorders. The patent specifically addresses conditions such as glioblastoma, hepatocellular carcinoma, liver cancer, colon cancer, and lung cancer, which are linked to altered cannabinoid receptor activity. The method includes administering an effective amount of a fenoterol analogue to a subject at risk of developing these disorders, aiming to reduce symptoms associated with the dysregulated CB receptor activity.

Career Highlights

Rajib Kumar Paul is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution underscores his commitment to advancing medical research and innovation in cannabinoid receptor activity.

Collaborations

Rajib has collaborated with esteemed colleagues such as Irving William Wainer and Michel Bernier. These partnerships reflect his engagement with other experts in the field, contributing to the advancement of research and innovation.

Conclusion

Rajib Kumar Paul is a prominent inventor whose work in cannabinoid receptor activity regulation has the potential to impact the treatment of various cancers and disorders. His innovative approaches and collaborations highlight his dedication to improving health outcomes through scientific research.